ANTIBIOTICS DOS

Diversity Oriented Synthesis of Peptide Derivatives as Antibiotics

Coordinatore	THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE    more  Organization address address: The Old Schools, Trinity Lane city: CAMBRIDGE postcode: CB2 1TN contact info Titolo: Ms. Nome: Edna Cognome: Murphy Email: send email Telefono: +44 1223 333543 Fax: +44 1223 332988
Nazionalità Coordinatore	United Kingdom [UK]
Totale costo	0 €
EC contributo	171˙867 €
Programma	FP7-PEOPLE Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
Code Call	FP7-PEOPLE-IEF-2008
Funding Scheme	MC-IEF
Anno di inizio	2009
Periodo (anno-mese-giorno)	2009-05-01   -   2011-04-30

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE  Organization address address: The Old Schools, Trinity Lane city: CAMBRIDGE postcode: CB2 1TN contact info Titolo: Ms. Nome: Edna Cognome: Murphy Email: send email Telefono: +44 1223 333543 Fax: +44 1223 332988	UK (CAMBRIDGE)	coordinator	171˙867.62

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'Our aim is to find new antibacterial molecules with novel mechanisms of action, by applying new and innovative approaches in organic and medicinal chemistry, such as diversity-oriented synthesis (DOS) and chemical genetics. The concrete objectives are: -Development of diversity-oriented synthesis (DOS) using solid phase and solution synthesis to obtain collections of highly diverse and complex small cyclic peptide derivatives including small cyclic di- tri- and tetra- peptides as well as bicyclic diketopiperazines (DKP's). -Development of new methodologies for solid phase organic synthesis: optimization of relatively new reactions such as RCM or enyne metathesis on solid phase. -Biological screening of the molecular libraries on cultures of human pathogen bacteria and selection of the most active compounds to identify new modes of antibacterial action. This project addresses major challenges in both therapeutics and organic synthesis, such as bacterial resistance to existing drugs, development of new methodologies for solid phase organic synthesis and diversity-oriented synthesis and chemical genetics in Europe. It is a multidisciplinary project that involves a highly valuable education for the candidate in new scientific aspects related to his research field.'